Introduction phoid cell line. First identified in plant satellite viruses, ribozymes are Ribozyme-mediated inhibition of HIV-1 replication has described as catalytic RNA molecules capable of recogalso been studied in human peripheral blood lymphonizing and cleaving a specific target RNA. The RNAcytes. A monomeric hammerhead ribozyme targeted binding domain of a ribozyme can be modified such that against the HIV-1 Tat coding region was shown to inhibit it can be designed against virtually any target RNA.
HIV-1 replication by up to 70% at day 12 after infection. 13 Ribozyme-mediated inactivation of HIV-1 RNAs within A monomeric hairpin ribozyme targeted against HIV-1 5′ the cell and/or virus particles therefore constitutes a untranslated region resulted in 1000-fold inhibition of promising form of anti-HIV-1 gene therapy. [1] [2] [3] HIV-1 replication for 10-25 days after infection. 23 This HIV-1 RNA-specific hammerhead ribozymes targeting hairpin ribozyme was also shown to inhibit HIV-1 replithe 5′ untranslated region, 4, 5 trans-activation responsive cation by up to 90% at day 6-10 after infection in (TAR) region, 6 regulator of expression of virion protein macrophage-like cells derived from stably transduced (Rev) response element and repeat regions, 7 packaging CD34 + hematopoietic stem cells from human cord signal region, 8 as well as group antigen, 9,10 polymerase, 7, 9 blood. 24 Env, 9, 11 trans-activator of transcription (Tat), 9, [12] [13] [14] [15] [16] The above studies suggest that although effective, Tat/Rev, 14 and Nef 17 coding regions have been shown monomeric ribozymes are unable to inhibit HIV-1 replito inhibit HIV-1 replication following transient or stable cation completely. Multimeric ribozymes may therefore expression in HeLa or human CD4 + T lymphoid cell lines. be designed that would consist of several monomeric Hairpin ribozymes were also designed against the HIV-1 ribozymes connected in tandem with each ribozyme 5′ leader sequence [18] [19] [20] and against the Rev/Env 9 coding targeting a different site. region and were shown to delay HIV-1 replication in Multimeric tRNA-based ribozymes have also been HeLa 18, 19 and lymphoid 20, 21 cell lines. In addition, a hairdesigned that could either remain connected or selfpin ribozyme with an improved catalytic activity was cleave to liberate individual ribozymes. 25, 26 Of these, the developed against HIV-1 Pol coding region 22 and shown self-cleaving ribozymes were shown to be more effective in vitro and the cleavage efficiency was shown to increase with the number of ribozymes. HIV-1 Env RNA specific di-, tetra-, penta-, and nonam- were shown in vitro to retain the specificity of monomeric ribozyme, Rz Env , and a multimeric ribozyme, Rz Env1-9 , respectively. pUCMoTiN, 27 the parent vector lacking any ribozymes. Furthermore, unlike monomeric ribozymes, the multimeric ribozymes, when expressed as part of a of the ribozymes, was used as a control. These vectors contain two promoters: the MoMLV 5′ long terminal large RNA transcript, were shown to be active against large RNA molecules containing the target sites. Followrepeat (LTR) promoter that allows vector RNA synthesis, and the herpes simplex virus type-1 (HSV-1) thymidine ing transient expression in HeLa-T4 cells, the nonameric ribozyme was shown to inhibit virus replication by 90% kinase (tk)-HIV-1 TAR fusion promoter 27 that allows Neo mRNA synthesis. Ribozymes were cloned downstream of at day 4 after infection.
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In this study, we compare the anti-HIV-1 potential of the neo gene such that they would be part of both the vector and the Neo mRNAs ( Figure 2 ). a monomeric ribozyme, Rz Env , with that of a multimeric ribozyme, Rz Env1-9 , directed against one and nine highly conserved regions within the HIV-1 Env coding region,
In vitro cleavage activities of cloned monomeric and multimeric hammerhead ribozymes respectively. The two types of ribozymes were cloned downstream of the neomycin phosphotransferase (neo)
Cleavage activity of ribozymes cloned in the retroviral vectors was demonstrated as follows ( Figure 3 ). Rz Env , gene in a Moloney murine leukemia virus (MoMLV)-based retroviral vector, pUCMoTiN. 5, 27 Amphotropic Rz Env1-9 , and HIV-1 Env target RNA containing all cleavage sites, were PCR-amplified from pUCMoTiN-Rz Env , MoTiN, MoTiN-Rz Env , and MoTiN-Rz Env1-9 vector particles were used to stably transduce a human CD4 + T pUCMoTiN-Rz Env1-9 , and pHXB⌬ENVCAT 28 vectors, respectively. These templates were transcribed to generlymphoid (MT4) cell line. The pools of stable transductants expressing mono-and multimeric ribozymes ate Rz Env RNA (87 nts; Figure 3 , lane 1), Rz Env1-9 RNA were then challenged with HIV-1 to assess the level of protection conferred.
Results
Retroviral vectors expressing monomeric and multimeric hammerhead ribozymes Rz Env is designed to cleave HIV-1 (NL4-3) RNA after the GUC at nucleotide (nt) 113 of the Env coding region (Figure 1 ). Rz Env1-9 consists of nine monomeric ribozymes in tandem that are designed to cleave HIV-1 (NL4-3) RNA after GUX at nts 113, 330, 359, 660, 735, 775, 882, 996 and 1297 of the Env coding region (Figure 1 ). All sites against which the monomeric and multimeric ribozymes were targeted consist of eight nts flanking either side of the cleavage sites and correspond to highly conserved sequences within the Env coding region of HIV-1 B subtype. These target sites are 100% conserved within the HXB2, MN, NL4-3, ALA1 and RF isolates of HIV-1. Rz Env1-9 , were engineered to express a monomeric HIV-1 susceptibility of stably transduced pools of MT4 cells expressing monomeric and multimeric the action of which ribozyme(s), it is clear that over 95% of the target RNA is cleaved by Rz .
hammerhead ribozymes The pools of stable MT4 transductants lacking or expressing mono-and multimeric ribozymes were infected with Development of stably transduced pools of MT4 cells expressing monomeric and multimeric hammerhead HIV-1 and the amount of viral p24 antigen present in the infected cell culture supernatants was determined (Figure ribozymes Amphotropic MoTiN (control), MoTiN-Rz Env , and 5). In control cells lacking any ribozyme, HIV-1 p24 antigen was detected as early as day 6 after infection. Cells MoTiN-Rz Env1-9 vector particles were used to infect MT4 cells. Pools of stably transduced MT4 cells lacking or expressing Rz Env were able to inhibit HIV-1 replication, but virus replication was only delayed by 9-12 days. expressing various ribozymes were selected and tested without cloning. Over 95% of the cells were found to be Interestingly, cells expressing Rz Env1-9 , were resistant to HIV-1 infection for 60 days after infection; a small CD4-positive by flow cytometry analysis using an anti-CD4 monoclonal antibody (results not shown).
amount of virus (5 pg; around the limit of sensitivity of the assay) was detected on day 21 after infection but all Vector and Neo RNA expression was confirmed by Northern blot analysis of total cellular RNA using a 32 Pother samples collected before and after this time-point were negative. Cells were regularly monitored and over labeled probe. Both vector and Neo RNAs could be detected (Figure 4a ). Relative concentration of these 90% of the Rz Env1-9 expressing cells were found to be viable at all times. RNAs remained unchanged between the MoTiN, MoTiNRz Env , and MoTiN-Rz Env1-9 vector-transduced cells Lack of virus replication in Rz Env1-9 -expressing cells was also confirmed by immunofluorescence using anti- (Figure 4a, lanes 2-4) virus particles of a partially reverse-transcribed genome. Another set of PCR primers was then used to PCR amplify the HIV LTR-Gag region that is synthesized after the second strand transfer. 31 A 952 bp PCR product was transport, and genomic RNA packaging. A ribozyme detected in this case (Figure 6a , lane 6) suggesting that a designed against a highly conserved sequence has a fraction of virus particles must contain a full length '−' better chance of inhibiting virus replication since escape strand DNA.
mutations are likely to confer a replication disadvantage HIV-infected Rz Env1-9 -expressing cells were also anato the virus. By increasing the number of sites targeted lyzed for the persistence or loss of HIV. The presence of within the HIV-RNA, using a multimeric ribozyme, one HIV DNA and RNA was therefore assessed by (RT) PCR could prevent the emergence of escape mutants much at day 60 after infection. HIV DNA (Figure 6b, lane 3) more effectively. Furthermore, multiple mutations within was readily detectable in the genome of HIV-infected a single coding region are likely to be more deleterious Rz Env1-9 -expressing MT4 transductants. However, HIV to the virus than if they were to span over various coding RNA could not be detected by RT-PCR (Figure 6b, lane 4) regions. Thus, multimeric ribozymes targeting various indirectly confirming Rz Env1-9 activity in vivo. As expected sites within a single essential coding region should prove Rz Env1-9 DNA (Figure 6b , lane 5) and RNA (Figure 6b , to be more effective than those targeting different sites lane 6) could be detected confirming continued but each situated in a different coding region. Since many expression of Rz . different sites within the HIV RNA are attacked, it is conceivable that all viral RNAs will be cleaved at least once which should result in complete inhibition of HIV Discussion replication. We report here the development and testing of MoTiN-HIV can quickly undergo mutations due to its errorprone reverse transcriptase that lacks a proof-reading based retroviral vectors expressing a monomeric and a multimeric ribozyme, targeting one and nine highly conmechanism. 32 Regions that are highly conserved amongst various strains of HIV may therefore encode for served sites within the HIV-1 Env coding region, respectively. All target sites were selected to be 100% conserved important functional domains within the viral proteins or contain important structural elements required for viral amongst at least five different isolates (including NL4-3) within the HIV-1 B subtype. reverse transcription, proviral DNA integration, gene expression, trans-activation of gene expression, RNA
In order to confirm that the cloned ribozymes are func-tional and capable of cleaving their target RNA, in vitro detected on day 3 after infection of Rz Env1-9 -expressing cells may result from infection by DNA-containing HIVcleavage reactions were performed to demonstrate cleavage of a 1443 nt-long RNA that contained all ribozyme 1 and/or be due to inability of Rz Env1-9 to access and cleave the incoming virion RNA. Note that this ribocleavage sites. Under suboptimal conditions used to assess the relative in vitro cleavage efficiency of these zyme is part of rather large RNA transcripts. Rz Env1-9 -expressing cells harboring HIV-1 provirus DNA could be ribozymes, Rz Env cleaved 15% of the input target RNA (Figure 3, lane 4) , whereas Rz Env1-9 cleaved over 95% of detected for the length of the experiment (up to 60 days). The presence of HIV proviral DNA at day 60 after infecthe target RNA (Figure 3, lane 5) . Several bands corresponding to Rz Env1-9 -mediated cleavage of target RNA at tion may be due to low level virus replication throughout the experiment. However, this is unlikely since if HIV different sites are visible indicating that ribozymes present within Rz Env1-9 are active. Because of a very comproviral DNA present in a single copy per cell could be detected, HIV RNA should have been detected too. It is plex pattern of cleavage products resulting from the action of single or multiple ribozymes present within the likely that Rz Env1-9 confers complete protection and that the proviral DNA-containing cells detected at day 60 Rz Env1-9 , it is difficult to assess the relative efficiency of individual ribozymes.
after infection originated from expansion of cells initially infected by the challenge virus. These cells would have Vector and Neo RNA expression within the pools of MT4 cells stably transduced with MoTiN, MoTiN-Rz Env , survived because of Rz Env1-9 -mediated inhibition of subsequent steps in viral replication. Since polyclonal popuand MoTiN-Rz Env1-9 vectors was confirmed by Northern blot analysis (Figure 4a ). The level of vector RNA lations of transduced MT4 cells were used to assess the level of protection conferred by the ribozymes, the results expressed from MoMLV 5′ LTR promoter, and Neo RNA expressed from tk-TAR fusion promoter, was similar obtained represent the average of resistance conferred by individual clones. As Rz Env1-9 conferred resistance to the among MoTiN, MoTiN-Rz Env , and MoTiN-Rz Env1-9 vector-transduced pools of MT4 cells. As expected, neither entire pool, all individual clones must have been resistant to HIV-1 replication. These results are very significant of these RNAs could be detected in the untransduced MT4 cells. Rz Env and Rz Env1-9 expression within the pools and indicate strongly that the MoTiN-Rz Env1-9 should prove to be useful in anti-HIV-1 gene therapy. of stable MT4 transductants was confirmed by RT-PCR. Expected size products, 218 bp for Rz Env (Figure 4b Retroviral vector constructions full length RNAs containing ribozymes were expressed pUCMoTiN-Rz Env vector was constructed as described and no recombination had occurred.
previously. 9 Rz Env1-9 was PCR amplified from pGem4-Rz Env and Rz Env1-9 were not cytotoxic as growth and Rz636 vector 11 using a 5′ primer (BglII-Rz Env1-9 -5′: viability of ribozyme-expressing pools of stable MT4 5′-ACG-GAA-GAT-CTC-ATA-TGC-CAT-AAT-ACT-G-3′) transductants were similar to those of control cells for up containing a BglII restriction site and a 3′ primer (Rz Env1-to 2 months of continuous culture. In addition, over 95% 9 -ClaI-3′: 5′-CGC-CAT-CGA-TTC-GCG-TAC-TAG-TAGof the cells were shown to be highly CD4 + , confirming C-3′) containing a ClaI site. The PCR product containing that transduction and ribozyme expression did not alter Rz Env1-9 was then digested with BglII and ClaI, and cloned surface CD4 expression.
into the pUCMoTiN vector at the same sites as described In HIV-1 challenge experiments, the monomeric previously. 5, 33 Ampicillin-and kanamycin-resistant colribozyme was shown to delay virus replication (Figure onies were isolated and the correct clone, pUCMoTiN-5). However, virus production eventually occurred and Rz Env1-9 , was confirmed by restriction enzyme and PCR reached values obtained for the control cells lacking any analysis. ribozyme. In contrast, the multimeric ribozyme was able to confer protection for the length of the experiment (60 days). HIV-1 replication was inhibited throughout with
In vitro cleavage activity of cloned ribozymes DNA templates containing ribozymes were PCRthe exception of one time-point at about 3 weeks after infection ( Figure 5 ). Values obtained for this time-point amplified as described previously 9 from pUCMoTiNRz Env and pUCMoTiN-Rz Env1-9 vectors using a common were very close to the limit of sensitivity of ELISA and therefore the possibility of this being a false positive can 5′ primer, T7-Rz-5′ (5′-ATA-TCA-TAT-GTA-ATA-CGA-
CTC-ACT-ATA-GGG-CGA-GAT-GGC-CGC-TTT-GGT-CC
not be ruled out. Lack of virus replication was also confirmed by immunofluorescence and RT-PCR (Figure 6b , 3′) containing the T7 promoter sequences (italicized) and Rz Env -3′ (5′-CGG-CCA-GAT-CTG-TCA-CAG-3′) and lane 4). Continued Rz Env1-9 expression in HIV-infected MoTiN-Rz Env1-9 vector-transduced MT4 cells was Rz Env1-9 -3′ (5′-GCT-CGT-ACT-CTA-TAG-GC-3′), respectively. DNA templates containing target sequences were confirmed by RT-PCR analysis on day 60 after HIV-1 challenge (Figure 6b, lane 6) .
PCR-amplified from pHXB⌬SVCAT plasmid using the T7-Env-5′ (5′-ATA-TCA-TAT-GTA-ATA-CGA-CTC-ACTOn day 3 after infection, HIV-1 provirus DNA could be detected within the genome of control, Rz Env , and ATA-GGG-CGA-GAA-GGA-GAA-ATA-TCA-GC-3′) and Env 1-9 -3′ (5′-TCA-CTT-CTC-CAA-TTG-TCC-3′) primer Rz Env1-9 -expressing MT4 transductants (Figure 6a, lanes  2-4) . A portion of HIV-1 used in challenge experiments pair; the T7 promoter sequences are italicized. PCR-amplified DNA templates (20 g) were then tranwas also shown to contain full length '−' strand DNA (Figure 6a, lane 6) . Infection, second-strand DNA synscribed and Rz Env , Rz , and the Env target RNA were used in trans cleavage reactions in vitro as described prethesis, and proviral DNA integration from such DNAcontaining HIV-1 would not be inhibited by the intraviously. 9 The cleavage products were analyzed by electrophoresis on an 8% polyacrylamide-8 m urea gel. cellularly expressed ribozymes. Thus, proviral DNA Transduction and selection of stably transduced MT4 again and fixed with 1% paraformaldehyde before the analysis. cells The ecotropic Psi-2 packaging cell line 34 was transfected HIV-1 susceptibility of stably transduced MT4 cells with the pUCMoTiN, pUCMoTiN-Rz Env , and pUCMoThe pools of stable MT4 transductants lacking or expressTiN-Rz Env1-9 DNAs as described previously. 35 The vector ing various ribozymes were infected with HIV-1 strain particles released from the pools of these transductants NL4-3, 43 at an MOI of 0.01, as described previously. 9 The were used to transduce the amphotropic PA317 packagculture supernatants were collected every 3 days and ing cell line. 36 Amphotropic MoTiN, MoTiN-Rz Env , and replaced with fresh medium. The amount of HIV-1 p24 MoTiN-Rz Env1-9 vector particles were used to transduce antigen produced in the cell culture supernatants was the MT4 cells 37, 38 as described previously. 39, 40 The pools determined by enzyme linked immunosorbent assay of G418-resistant stable MT4 transductants lacking (ELISA; Abbott, Chicago, USA). The HIV-1 challenge (control) or expressing various ribozymes were then experiment was performed twice. selected and analyzed without further cloning.
To determine the percentage of HIV-infected cells immunofluorescence was performed as follows. Cells Northern blot analysis (5 × 10 3 ) were washed twice with PBS, air-dried overnight Total cellular RNA from untransduced MT4 cells, and on glass slides, fixed with cold acetone, and incubated from MoTiN, MoTiN-Rz Env , and MoTiN-Rz Env1-9 vectorwith heat-inactivated pooled AIDS patients' serum (2 g) transduced MT4 cells was prepared by an acid guanidfor 45 min at 37°C. The cells were then washed three ium thiocyanate method. 41 A 1250 bp 32 P-labeled probe times with PBS, blot-dried, and incubated with FITCcontaining the 3′ untranslated region of Neo mRNA was labelled goat-anti-human antibodies (2 g; Coulter prepared by PCR-amplification of pUCMoTiN DNA Electronics) for 45 min at 37°C. They were then washed using UTR-5′ (5′-GAT-GGC-CGC-TTT-GGT-CC-3′) and three times with PBS and observed under a fluorescence UTR-3′ (5′-GGC-TCG-TAC-TCT-ATA-GG-3′) primers as microscope (Zeiss, Toronto, Canada). described above except that 50 Ci of ␣ 32 P-dATP (3000 In order to confirm the presence of HIV-1 proviral Ci/mmol; Amersham, Oakville, Canada) was added in a DNA within the cellular genome, PCR analysis was per-200 l PCR. The 32 P-labeled-PCR product was then puriformed using genomic DNA (1 g) isolated on day 3 folfied by chromatography on a Sephadex G50 (Pharmacia, lowing HIV-1 challenge of the pools of stably transduced Baie D'Urfé, Canada) column. Total cellular RNA (10 g) MT4 cells lacking or expressing various ribozymes and was resolved on a 1% agarose gel containing formalusing DNA extracted from HIV particles used in the chaldehyde and transferred on to a Hybond-N + membrane lenge experiments. PCRs were performed as described (Amersham) in 10 × SSC. The membrane was baked for above except that LTR-5′ (5′-GTT-AGA-GTG-GAG-GTT-2 h at 80°C and prehybridized for 2 h at 42°C with 50% TG-3′) and LTR-3′ (5′-TTG-AGG-CTT-AAG-CAG-TGGdeionized formamide, 1% SDS, 0.75 m NaCl, 0.5 × 3′) primers were used. GAPDH-5′ and GAPDH-3′ primer Denhardt's solution, 10% Dextran sulfate, and 0.18 pair was used as control. In parallel, DNA extracted from mg/ml denatured salmon sperm DNA. Denatured 32 P-HIV particles used in challenge experiments was PCR labeled probe was then added and hybridization proanalyzed using LTR-5′/LTR-3′ and LTR-5′/Gag-3′ (5′-ceeded overnight at 42°C. Membranes were washed once GAT-GTT-CTG-CAC-TAT-AGG-G-3′) primer pairs. in 1 × SSC, 0.1% SDS at room temperature and once in At day 60 after HIV challenge of MoTiN-Rz Env1-9 -vector 0.1 × SSC, 0.1% SDS at 65°C. The blot was then exposed transduced MT4 cells, the genomic DNA and the total overnight at −80°C with XAR-5 X-ray film (Kodak, RNA were extracted and analyzed by PCR and RT-PCR, Toronto, Canada).
respectively. (RT)-PCRs were performed using Psi-5′ (5′-ATA-GTA-TGG-GCA-AGC-AGG-G-3′)/Gag-3′, T7-Rz-RT-PCR analysis 5′/Rz-3′, and GAPDH-5′/GAPDH-3′ primer pairs. The total RNA extracted from stable MT4 transductants lacking or expressing various ribozymes 41 was incubated with DNase RQ1 (Promega, Unionville, Canada) for 15
